PL113208B1 - Process for preparing novel phthalazine derivatives - Google Patents

Process for preparing novel phthalazine derivatives Download PDF

Info

Publication number
PL113208B1
PL113208B1 PL1978207337A PL20733778A PL113208B1 PL 113208 B1 PL113208 B1 PL 113208B1 PL 1978207337 A PL1978207337 A PL 1978207337A PL 20733778 A PL20733778 A PL 20733778A PL 113208 B1 PL113208 B1 PL 113208B1
Authority
PL
Poland
Prior art keywords
group
formula
radical
free base
lower alkoxy
Prior art date
Application number
PL1978207337A
Other languages
English (en)
Polish (pl)
Other versions
PL207337A1 (pl
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PL207337A1 publication Critical patent/PL207337A1/xx
Publication of PL113208B1 publication Critical patent/PL113208B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL1978207337A 1977-06-03 1978-06-02 Process for preparing novel phthalazine derivatives PL113208B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2358277 1977-06-03

Publications (2)

Publication Number Publication Date
PL207337A1 PL207337A1 (pl) 1979-06-04
PL113208B1 true PL113208B1 (en) 1980-11-29

Family

ID=10198020

Family Applications (3)

Application Number Title Priority Date Filing Date
PL1978207337A PL113208B1 (en) 1977-06-03 1978-06-02 Process for preparing novel phthalazine derivatives
PL1978217897A PL116437B1 (en) 1977-06-03 1978-06-02 Process for preparing novel phthalazine derivatives
PL1978217896A PL116420B1 (en) 1977-06-03 1978-06-02 Process for preparing novel phthalazine derivatives

Family Applications After (2)

Application Number Title Priority Date Filing Date
PL1978217897A PL116437B1 (en) 1977-06-03 1978-06-02 Process for preparing novel phthalazine derivatives
PL1978217896A PL116420B1 (en) 1977-06-03 1978-06-02 Process for preparing novel phthalazine derivatives

Country Status (29)

Country Link
US (1) US4289772A (enExample)
JP (1) JPS5416488A (enExample)
AR (2) AR222013A1 (enExample)
AT (2) AT362792B (enExample)
AU (1) AU505373B1 (enExample)
BE (1) BE867727A (enExample)
CA (1) CA1111850A (enExample)
DD (1) DD137355A5 (enExample)
DE (1) DE2824064A1 (enExample)
DK (1) DK248078A (enExample)
EG (1) EG13527A (enExample)
ES (4) ES470470A1 (enExample)
FI (1) FI781753A7 (enExample)
FR (1) FR2392986A1 (enExample)
GB (1) GB2000136B (enExample)
GR (1) GR74402B (enExample)
HU (1) HU179745B (enExample)
IL (1) IL54842A (enExample)
IN (3) IN148482B (enExample)
IT (1) IT1094944B (enExample)
LU (1) LU79761A1 (enExample)
NL (1) NL7806016A (enExample)
NO (1) NO781935L (enExample)
NZ (1) NZ187453A (enExample)
PL (3) PL113208B1 (enExample)
PT (1) PT68126A (enExample)
SE (1) SE7806519L (enExample)
SU (2) SU856383A3 (enExample)
ZA (1) ZA783183B (enExample)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370328A (en) * 1977-11-03 1983-01-25 Pfizer Inc. Cardiac stimulant 1-(3- or 4-substituted piperidino)phthalazines
IL59619A0 (en) * 1979-03-28 1980-06-30 Pfizer Phthalazine derivatives,their preparation and pharmaceutical compositions containing them
PL135545B1 (en) * 1980-03-01 1985-11-30 Wyeth John & Brother Ltd Process for preparing novel derivatives of piperidine
GB8320958D0 (en) * 1983-08-03 1983-09-07 Pfizer Ltd Quinazoline cardiac stimulants
US5001125A (en) * 1984-03-26 1991-03-19 Janssen Pharmaceutica N.V. Anti-virally active pyridazinamines
US4882354A (en) * 1987-12-16 1989-11-21 Norwich Eaton Pharmaceuticals, Inc. N-hydroxy-5-phenyl-2-furancarboximidamides useful as cardiotonic agents
JP3169188B2 (ja) * 1991-01-31 2001-05-21 杏林製薬株式会社 カルバミン酸誘導体及びその製造方法
US5300515A (en) * 1991-01-31 1994-04-05 Kyorin Pharmaceutical Co., Ltd. Carbamic acid derivatives and method for preparing the same
EP0621267A1 (en) * 1993-04-07 1994-10-26 Shell Internationale Researchmaatschappij B.V. Spiropiperidine derivatives and their use as fungicides
US5728712A (en) * 1995-05-19 1998-03-17 Chiroscience Limited 3,4-disubstituted-phenylsulphonamides and their therapeutic use
KR100485249B1 (ko) * 1996-08-20 2005-09-09 에자이 가부시키가이샤 축합피리다진계화합물의발기기능부전증치료제
US20030186963A1 (en) 2001-09-14 2003-10-02 Dorwald Florencio Zaragoza Substituted piperidines
US20040224986A1 (en) * 2002-08-16 2004-11-11 Bart De Corte Piperidinyl targeting compounds that selectively bind integrins
EP1539739B1 (en) * 2002-08-16 2010-11-24 Janssen Pharmaceutica NV Piperidinyl compounds that selectively bind integrins
US20060019975A1 (en) * 2004-07-23 2006-01-26 Pfizer Inc Novel piperidyl derivatives of quinazoline and isoquinoline
TW200630337A (en) 2004-10-14 2006-09-01 Euro Celtique Sa Piperidinyl compounds and the use thereof
EP2275096A3 (en) 2005-08-26 2011-07-13 Braincells, Inc. Neurogenesis via modulation of the muscarinic receptors
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
WO2007047978A2 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
EP2314289A1 (en) 2005-10-31 2011-04-27 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100222353A1 (en) * 2006-01-27 2010-09-02 Pfizer Products Inc. Aminophthalazine derivative compounds
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007110449A1 (en) 2006-03-29 2007-10-04 Euro-Celtique S.A. Benzenesulfonamide compounds and their use
TW200812963A (en) 2006-04-13 2008-03-16 Euro Celtique Sa Benzenesulfonamide compounds and the use thereof
WO2007118853A1 (en) 2006-04-13 2007-10-25 Euro-Celtique S.A. Benzenesulfonamide compounds and their use as blockers of calcium channels
EP2021000A2 (en) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenesis by modulating angiotensin
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
EP1900731A1 (de) * 2006-09-07 2008-03-19 Bayer Schering Pharma Aktiengesellschaft N-(1-Phthalazin-1-yl-piperidin-4-yl)-amide als EP2-Rezeptor Modulatoren
EP1903037A1 (de) * 2006-09-07 2008-03-26 Bayer Schering Pharma Aktiengesellschaft 1-(Het)aryl-3-[hetaryl-piperidin-4-yl]-thioharnstoffe als Modulatoren des EP2-Rezeptors
WO2008030651A1 (en) 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2008124118A1 (en) 2007-04-09 2008-10-16 Purdue Pharma L.P. Benzenesulfonyl compounds and the use therof
JP2010535733A (ja) 2007-08-07 2010-11-25 エフ．ホフマン−ラ ロシュ アーゲー Ｎｋ３受容体アンタゴニストとしてのピロリジンアリールエーテル
AU2008290634B2 (en) 2007-08-22 2012-12-06 F. Hoffmann-La Roche Ag Pyrrolidine aryl-ether as NK3 receptor antagonists
WO2009033995A1 (en) * 2007-09-14 2009-03-19 F. Hoffmann-La Roche Ag Piperidine derivatives as nk3 receptor antagonists
WO2009040659A2 (en) 2007-09-28 2009-04-02 Purdue Pharma L.P. Benzenesulfonamide compounds and the use thereof
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
AR077014A1 (es) 2009-06-19 2011-07-27 Lilly Co Eli Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
JP7868066B2 (ja) 2020-10-13 2026-06-01 エンデバー バイオメディシンズ， インコーポレイテッド 線維症を処置する方法
US12605377B2 (en) 2020-10-13 2026-04-21 Endeavor Biomedicines, Inc. Methods of treating fibrosis
CN113087654B (zh) * 2021-04-15 2022-12-23 苏州昊帆生物股份有限公司 哌啶-4-丁胺的制备方法
US12447148B2 (en) 2024-03-05 2025-10-21 Endeavor Biomedicines, Inc. Methods of improving lung function

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1094044A (en) * 1965-07-12 1967-12-06 Vantorex Ltd Phthalazine derivatives
GB1199768A (en) 1966-10-31 1970-07-22 Pfizer & Co C Nitrogen Heterocycles and process for their preparation
GB1293565A (en) * 1969-05-03 1972-10-18 Aspro Nicholas Ltd Aminophthalazines and pharmaceutical compositions thereof
GB1460389A (en) 1974-07-25 1977-01-06 Pfizer Ltd 4-substituted quinazoline cardiac stimulants

Also Published As

Publication number Publication date
ES478200A1 (es) 1980-01-01
EG13527A (en) 1981-12-31
ATA305080A (de) 1980-12-15
SU856383A3 (ru) 1981-08-15
PL116437B1 (en) 1981-06-30
PL207337A1 (pl) 1979-06-04
JPS5538351B2 (enExample) 1980-10-03
NO781935L (no) 1978-12-05
IN148482B (enExample) 1981-03-07
IT7824106A0 (it) 1978-06-01
DE2824064A1 (de) 1978-12-14
PL116420B1 (en) 1981-06-30
ES470470A1 (es) 1979-09-01
GR74402B (enExample) 1984-06-28
DK248078A (da) 1978-12-04
AR222013A1 (es) 1981-04-15
ATA400878A (de) 1980-11-15
IL54842A (en) 1982-01-31
IT1094944B (it) 1985-08-10
US4289772A (en) 1981-09-15
SU862826A3 (ru) 1981-09-07
AT363096B (de) 1981-07-10
IN149550B (enExample) 1982-01-16
IL54842A0 (en) 1978-08-31
AT362792B (de) 1981-06-10
ES478201A1 (es) 1980-02-01
IN149973B (enExample) 1982-06-19
GB2000136A (en) 1979-01-04
AU505373B1 (en) 1979-11-15
CA1111850A (en) 1981-11-03
FR2392986B1 (enExample) 1982-07-16
NL7806016A (nl) 1978-12-05
NZ187453A (en) 1980-12-19
FI781753A7 (fi) 1978-12-04
PT68126A (en) 1978-07-01
ES478199A1 (es) 1980-01-16
BE867727A (fr) 1978-12-01
GB2000136B (en) 1982-01-06
ZA783183B (en) 1979-06-27
LU79761A1 (fr) 1980-01-22
SE7806519L (sv) 1978-12-04
DD137355A5 (de) 1979-08-29
AR223999A1 (es) 1981-10-15
HU179745B (en) 1982-12-28
FR2392986A1 (fr) 1978-12-29
JPS5416488A (en) 1979-02-07

Similar Documents

Publication Publication Date Title
PL116437B1 (en) Process for preparing novel phthalazine derivatives
EP0079545B1 (en) Benzimidazole derivatives, process for the preparation thereof and pharmaceutical composition containing the same
JPH02273676A (ja) 新規化合物、その製法及びそれを含む医薬組成物
BRPI0519424B1 (pt) compostos, composição e uso dos ditos compostos para a preparação de um medicamento para prevenção ou tratamento de um distúrbio de proliferação celular ou infecção microbiana
EP0159566A1 (en) Novel piperazine derivatives, processes for production thereof, and pharmaceutical compositions comprising said compounds as active ingredient
IL125076A (en) Aza compounds, diazole cycloheptane and converted cyclooctane compounds and pharmaceutical preparations containing them
JPH10279477A (ja) ベンジリデン−およびシンナミリデン−マロンニトリル誘導体を有効成分として含有する哺乳類細胞での増殖工程の抑制のためのタンパク質チロシンキナーゼ阻害剤
PL101099B1 (pl) Sposob wytwarzania nowych trojchloroacetamidyn
CN113831338A (zh) 一种组蛋白去乙酰化酶抑制剂及其制备方法和应用
EP0784055A1 (en) Pyrimidinylpyrazole derivative
JPH05247069A (ja) アミノアルカンホスフィン酸およびその塩
JPH0310616B2 (enExample)
PT1727817E (pt) Derivados de azabiciclooctan-3-ona e seu uso
HUE031676T2 (en) An effective medicine for neuropathic pain
SK2722002A3 (en) Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia
WO2021194623A1 (en) 8-substituted diaryl xanthines as dual a 2a-a 2b antagonists
PT98372A (pt) Processo de preparacao de derivados de benzidrilo com propriedades inibidoras da calmodulina e de composicoes farmaceuticas
PL128998B1 (en) Process for preparing novel 2-amino-3-benzoylphenylacetamides and their derivatives
WO1996016942A1 (en) Pyridine derivatives
DE3779813T2 (de) 1,4-dihydropyridinderivate.
JP2004509106A (ja) ニコチン性アセチルコリン受容体アゴニストとしての（２−アザ−ビシクロ［２．２．１］ヘプト−７−イル）メタノール誘導体
PL97347B1 (pl) Sposob wytwarzania nowych 2-fenylohydrazyno-tiazolin lub-tiazyn
US5332743A (en) Benzyl and benzhydryl alcohols
EP3749306B1 (en) Nicotinamide phosphoribosyltransferase inhibitors and methods for use of the same
US4206217A (en) 3-[4-(1,3-Diazacycloalken-2-yl)-phenyl]-1,2-benzisothiazoles, their manufacture, and drugs containing these compounds